Skip to main content

Table 1 Patient and tumor characteristics

From: The value of whole-lesion histogram analysis based on field‑of‑view optimized and constrained undistorted single shot (FOCUS) DWI for predicting axillary lymph node status in early-stage breast cancer

Variable

N0 (n = 45)

N1–2 (n = 16)

N≥3 (n = 20)

F/χ2

P values

Age (years)a

57.64 ± 10.04

58.44 ± 12.32

51.55 ± 10.31

2.706

0.073

Lesion size(cm)b

1.70 (0.70)

2.25 (1.38)

3.00 (1.15)

20.092

0.000

Tumor Positionc

0.606

0.739

Outer upper

19 (42.2)

6 (37.5)

10 (50.0)

Others

26 (57.8)

10 (62.5)

10 (50.0)

ERc

0.462

0.479

Positive

34 (75.6)

15 (93.8)

16 (80.0)

Negative

11 (24.4)

1 (6.2)

4 (20.0)

PRc

0.649

0.723

Positive

29 (64.4)

12 (75.0)

13 (65.0)

Negative

16 (35.6)

4 (25.0)

7 (35.0)

HER2c

3.4145

0.065

Positive

6 (13.3)

1 (6.2)

7 (35.0)

Negative

39 (86.7)

15 (93.8)

13 (65.0)

Ki-67c

0.997

0.318

Positive

37 (82.2)

15 (93.8)

18 (90.0)

Negative

8 (17.8)

1 (6.2)

2 (10.0)

Molecular subtypec

9.800

0.133

Luminal A

8 (17.8)

1 (6.2)

2 (10.0)

Luminal B

26 (57.8)

14 (87.5)

14 (70.0)

HER2 positive

1 (2.2)

1 (6.2)

1 (5.0)

Triple negative

10 (22.2)

0 (0)

3 (15.0)

Histologic gradec

5.161

0.076

I/II

24 (53.3)

9 (56.2)

5 (25.0)

III

21 (46.7)

7 (43.8)

15 (75.0)

  1. aData are presented as mean value ± standard deviation
  2. bData are presented as median (interquartile range)
  3. cCategorical variables are numbers with percentages in parentheses
  4. ER  estrogen receptor, PR  progesterone receptor, HER2  human epidermal growth factor receptor-2